Selected research
Industry Research
Artificial Intelligence Drug Discovery Platform Industry Research Report 2026
Market perspective
The global Artificial Intelligence Drug Discovery Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Artificial Intelligence Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Artificial Intelligence Drug Discovery Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Artificial Intelligence Drug Discovery Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Artificial Intelligence Drug Discovery Platform include BenevolentAI, Schrödinger, Numerion Labs, XtalPi, Tencent, NVIDIA, Insilico Medicine, Iambic Therapeutics and insitro, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Artificial Intelligence Drug Discovery Platform market in terms of revenue (US$ million) and, where applicable, service volume (Unit), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artificial Intelligence Drug Discovery Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Intelligence Drug Discovery Platform Market by Company
BenevolentAI
Schrödinger
Numerion Labs
XtalPi
Tencent
NVIDIA
Insilico Medicine
Iambic Therapeutics
insitro
Valo Health
Genesis
DeepCure
Nimbus Therapeutics
Absci
Owkin
Eli Lilly
Recursion
Artificial Intelligence Drug Discovery Platform Segment by Type
Small Molecule Platform
Biomacromolecule Platform
Others
Artificial Intelligence Drug Discovery Platform Segment by Application
Pharmaceutical Companies
Research Institutions
Others
Artificial Intelligence Drug Discovery Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Drug Discovery Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Artificial Intelligence Drug Discovery Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Molecule Platform
- Biomacromolecule Platform
- Others
Applications
- Pharmaceutical Companies
- Research Institutions
- Others
Companies covered
- BenevolentAI
- Schrödinger
- Numerion Labs
- XtalPi
- Tencent
- NVIDIA
- Insilico Medicine
- Iambic Therapeutics
- insitro
- Valo Health
- Genesis
- DeepCure
- Nimbus Therapeutics
- Absci
- Owkin
- Eli Lilly
- Recursion
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artificial Intelligence Drug Discovery Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Small Molecule Platform
- 2.2.3 Biomacromolecule Platform
- 2.2.4 Others
- 2.3 Artificial Intelligence Drug Discovery Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Research Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Artificial Intelligence Drug Discovery Platform Breakdown Data by Type
- 3.1 Global Artificial Intelligence Drug Discovery Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Artificial Intelligence Drug Discovery Platform Forecasted Market Size by Type (2027-2032)
4 Artificial Intelligence Drug Discovery Platform Breakdown Data by Application
- 4.1 Global Artificial Intelligence Drug Discovery Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Artificial Intelligence Drug Discovery Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Artificial Intelligence Drug Discovery Platform Market Perspective (2021-2032)
- 5.2 Global Artificial Intelligence Drug Discovery Platform Growth Trends by Region
- 5.2.1 Global Artificial Intelligence Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Artificial Intelligence Drug Discovery Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Artificial Intelligence Drug Discovery Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Artificial Intelligence Drug Discovery Platform Market Dynamics
- 5.3.1 Artificial Intelligence Drug Discovery Platform Industry Trends
- 5.3.2 Artificial Intelligence Drug Discovery Platform Market Drivers
- 5.3.3 Artificial Intelligence Drug Discovery Platform Market Challenges
- 5.3.4 Artificial Intelligence Drug Discovery Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Artificial Intelligence Drug Discovery Platform Players by Revenue
- 6.1.1 Global Top Artificial Intelligence Drug Discovery Platform Players by Revenue (2021-2026)
- 6.1.2 Global Artificial Intelligence Drug Discovery Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Artificial Intelligence Drug Discovery Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Artificial Intelligence Drug Discovery Platform Head Office and Area Served
- 6.4 Global Artificial Intelligence Drug Discovery Platform Players, Product Type & Application
- 6.5 Global Artificial Intelligence Drug Discovery Platform Manufacturers Established Date
- 6.6 Global Artificial Intelligence Drug Discovery Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Artificial Intelligence Drug Discovery Platform Market Size (2021-2032)
- 7.2 North America Artificial Intelligence Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Artificial Intelligence Drug Discovery Platform Market Size by Country (2021-2026)
- 7.4 North America Artificial Intelligence Drug Discovery Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Artificial Intelligence Drug Discovery Platform Market Size (2021-2032)
- 8.2 Europe Artificial Intelligence Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Artificial Intelligence Drug Discovery Platform Market Size by Country (2021-2026)
- 8.4 Europe Artificial Intelligence Drug Discovery Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Artificial Intelligence Drug Discovery Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Artificial Intelligence Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Artificial Intelligence Drug Discovery Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Artificial Intelligence Drug Discovery Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Artificial Intelligence Drug Discovery Platform Market Size (2021-2032)
- 10.2 South America Artificial Intelligence Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Artificial Intelligence Drug Discovery Platform Market Size by Country (2021-2026)
- 10.4 South America Artificial Intelligence Drug Discovery Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Artificial Intelligence Drug Discovery Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Artificial Intelligence Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Artificial Intelligence Drug Discovery Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Artificial Intelligence Drug Discovery Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BenevolentAI
- 12.1.1 BenevolentAI Company Information
- 12.1.2 BenevolentAI Business Overview
- 12.1.3 BenevolentAI Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.1.4 BenevolentAI Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.1.5 BenevolentAI Recent Developments
- 12.2 Schrödinger
- 12.2.1 Schrödinger Company Information
- 12.2.2 Schrödinger Business Overview
- 12.2.3 Schrödinger Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.2.4 Schrödinger Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.2.5 Schrödinger Recent Developments
- 12.3 Numerion Labs
- 12.3.1 Numerion Labs Company Information
- 12.3.2 Numerion Labs Business Overview
- 12.3.3 Numerion Labs Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.3.4 Numerion Labs Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.3.5 Numerion Labs Recent Developments
- 12.4 XtalPi
- 12.4.1 XtalPi Company Information
- 12.4.2 XtalPi Business Overview
- 12.4.3 XtalPi Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.4.4 XtalPi Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.4.5 XtalPi Recent Developments
- 12.5 Tencent
- 12.5.1 Tencent Company Information
- 12.5.2 Tencent Business Overview
- 12.5.3 Tencent Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.5.4 Tencent Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.5.5 Tencent Recent Developments
- 12.6 NVIDIA
- 12.6.1 NVIDIA Company Information
- 12.6.2 NVIDIA Business Overview
- 12.6.3 NVIDIA Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.6.4 NVIDIA Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.6.5 NVIDIA Recent Developments
- 12.7 Insilico Medicine
- 12.7.1 Insilico Medicine Company Information
- 12.7.2 Insilico Medicine Business Overview
- 12.7.3 Insilico Medicine Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.7.4 Insilico Medicine Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.7.5 Insilico Medicine Recent Developments
- 12.8 Iambic Therapeutics
- 12.8.1 Iambic Therapeutics Company Information
- 12.8.2 Iambic Therapeutics Business Overview
- 12.8.3 Iambic Therapeutics Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.8.4 Iambic Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.8.5 Iambic Therapeutics Recent Developments
- 12.9 insitro
- 12.9.1 insitro Company Information
- 12.9.2 insitro Business Overview
- 12.9.3 insitro Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.9.4 insitro Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.9.5 insitro Recent Developments
- 12.10 Valo Health
- 12.10.1 Valo Health Company Information
- 12.10.2 Valo Health Business Overview
- 12.10.3 Valo Health Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.10.4 Valo Health Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.10.5 Valo Health Recent Developments
- 12.11 Genesis
- 12.11.1 Genesis Company Information
- 12.11.2 Genesis Business Overview
- 12.11.3 Genesis Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.11.4 Genesis Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.11.5 Genesis Recent Developments
- 12.12 DeepCure
- 12.12.1 DeepCure Company Information
- 12.12.2 DeepCure Business Overview
- 12.12.3 DeepCure Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.12.4 DeepCure Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.12.5 DeepCure Recent Developments
- 12.13 Nimbus Therapeutics
- 12.13.1 Nimbus Therapeutics Company Information
- 12.13.2 Nimbus Therapeutics Business Overview
- 12.13.3 Nimbus Therapeutics Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.13.4 Nimbus Therapeutics Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.13.5 Nimbus Therapeutics Recent Developments
- 12.14 Absci
- 12.14.1 Absci Company Information
- 12.14.2 Absci Business Overview
- 12.14.3 Absci Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.14.4 Absci Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.14.5 Absci Recent Developments
- 12.15 Owkin
- 12.15.1 Owkin Company Information
- 12.15.2 Owkin Business Overview
- 12.15.3 Owkin Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.15.4 Owkin Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.15.5 Owkin Recent Developments
- 12.16 Eli Lilly
- 12.16.1 Eli Lilly Company Information
- 12.16.2 Eli Lilly Business Overview
- 12.16.3 Eli Lilly Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.16.4 Eli Lilly Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.16.5 Eli Lilly Recent Developments
- 12.17 Recursion
- 12.17.1 Recursion Company Information
- 12.17.2 Recursion Business Overview
- 12.17.3 Recursion Revenue in Artificial Intelligence Drug Discovery Platform Business (2021-2026)
- 12.17.4 Recursion Artificial Intelligence Drug Discovery Platform Product Portfolio
- 12.17.5 Recursion Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst